| Short Description : | Recombinant-MERS-CoV Spike RBD-C-mFc protein was developed in hek293 cells using the region Glu367-Tyr606. For use in research applications. |
| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: | Measured by its binding ability in a functional ELISA. Immobilized Human CD26 at 2 Mu g/mL (100 Mu L/well) can bind MERS-CoV Spike RBD with a linear range of 0.5-139.82ng/mL. |
| Determination Method: | < 0.1 EU/Mu g of the protein by LAL method. |
| Immunogen: | Recombinant MERS-CoV Spike RBD Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Glu367-Tyr606) of mers-cov Spike RBD (Accession #YP_009047204.1) fused with a K9N5Q8. |
| Immunogen Region: | Glu367-Tyr606 |
| Immunogen Sequence: | EAKPSGSVVEQAEGVECDFS PLLSGTPPQVYNFKRLVFTN CNYNLTKLLSLFSVNDFTCS QISPAAIASNCYSSLILDYF SYPLSMKSDLSVSSAGPISQ FNYKQSFSNPTCLILATVPH NLTTITKPLKYSYINKCSRL LSDDRTEVPQLVNANQYSPC VSIVPSTVWEDGDYYRKQLS PLEGGGWLVASGSTVAMTEQ LQMGFGITVQYGTDTNSVCP KLEFANDTKIASQLGNCVE |
| Background | Recombinant MERS-CoV Spike RBD Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Glu367-Tyr606) of mers-cov Spike RBD (Accession #YP_009047204.1) fused with a K9N5Q8. |
Information sourced from Uniprot.org
